Nishadil
Signup Signin
Delhi | 25°C (windy)
Novo Nordisk Shifts Focus: Why the Cell Therapy Unit is Closing Its Doors

Novo Nordisk Shifts Focus: Why the Cell Therapy Unit is Closing Its Doors
Cagrisema: Novo Nordisk's Dual-Action Powerhouse Poised to Revolutionize Obesity Treatment

Cagrisema: Novo Nordisk's Dual-Action Powerhouse Poised to Revolutionize Obesity Treatment
Transatlantic Tremors: How US Drug Pricing Reforms Are Reshaping the Global Pharmaceutical Landscape

Transatlantic Tremors: How US Drug Pricing Reforms Are Reshaping the Global Pharmaceutical Landscape
Metsera: The New Power Player Set to Disrupt the $100 Billion GLP-1 Market

Metsera: The New Power Player Set to Disrupt the $100 Billion GLP-1 Market
The Cost-Benefit Revolution: GLP-1 Drugs Deemed Value-Packed, But Price Tags Loom Large

The Cost-Benefit Revolution: GLP-1 Drugs Deemed Value-Packed, But Price Tags Loom Large
Load more..